At the Proteomics Symposium (from left) are Marjan Gucek, PhD, Director, Proteomics Core Facility, NHLBI/NIH; Majid Ghassemian, PhD, Director of BMPSF; and Paul Mills, PhD, Co-Director of CTRI's Translational Research Technology Division. Gucek, one of the keynote speakers, discussed, "Targeting Mitochondria – From Protein Post-translational Modifications to Disease." Ghassemian and Mills co-organized the event.
October 21, 2014 – The "Frontiers of Proteomics Research Symposium" co-hosted by UC San Diego Clinical and Translational Research Institute (CTRI) and UC San Diego Biomolecular and Proteomics Mass Spectrometry Facility (BMPSF) on October 17 drew about 80 clinicians, researchers, students, and others. The all-day symposium took place at the Telemedicine Learning Center on the UC San Diego School of Medicine campus.
John Yates, PhD, delivered one of the symposium keynote talks, "Proteomics and Neurobiology." Yates, considered the father of modern proteomics, is the Ernest W. Hahn Professor, Chemical Physiology and Molecular and Cellular Neurobiology, at The Scripps Research Institute in La Jolla.
The symposium featured presentations on a range of cutting edge topics and proteomics technologies as applied to clinical research samples and introduced proteomic technologies offered at BMPSF and how these technologies can be applied to biological samples.
Pioneering proteomics researchers highlighted the current state of proteomic research and CTRI Catalyst (seed) grant recipients presented CTRI-sponsored proteomic research findings. Presenters were selected from a wide spectrum of research interests to demonstrate the applicability of proteomic approaches in various medical research areas.
"CTRI was pleased and enthused to have the opportunity to work closely with Dr. Majid Ghassemian, Director of UCSD's Biomolecular and Proteomics Mass Spectrometry Facility, to organize and offer this Frontiers of Proteomics Symposium to our community of scientists and clinicians," said Professor Paul Mills, co-director of the CTRI Translational Research Technology unit and co-organizer of the symposium. "We were fortunate to have two leaders in the field as keynote speakers, Dr. John Yates, of The Scripps Research Institute, and Dr. Marjan Gucek, Director of the NIH Proteomics Core Facility."
Click here to view a complete list of speakers and topics.
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.